Sustainable care for children with cancer: a Lancet Oncology Commission

Dr Ali Landman has been Deputy Editor of The Lancet Oncology since March, 2019. She earned her PhD in Cancer Biology from MIT (Cambridge, MA, USA) in 2009, and pursued post-doctoral research in cancer biology at the University of California San Francisco, University College London, and MRC Harwell, before joining The Lancet Oncology in January, 2015, as a Senior Editor.

Carlos Rodriguez-Galindo, M.D., is the director of the St. Jude Global program at St. Jude Children’s Research Hospital and an executive vice president within the organization. He is also the chair of the Department of Global Pediatric Medicine and holds the Four Stars of Chicago Endowed Chair in International Pediatric Research. In addition to his global work, Dr. Rodriguez-Galindo’s clinical research has focused in retinoblastoma, bone sarcomas, histiocytic disorders and rare childhood cancers, and has been the primary investigator of several clinical studies at St. Jude and Dana-Farber/Boston Children’s Cancer Center. Dr. Rodriguez-Galindo is the Chair of the Rare Tumors Committee at the Children’s Oncology Group (COG) and the primary investigator of COG studies for nasopharyngeal carcinoma, adrenocortical carcinoma, and recurrent malignant germ cell tumors. He is also the past-President of the Histiocyte Society and co-PI of the frontline LCH-IV study.

Dr Claudia Allemani is an Associate Professor of Cancer Epidemiology at the London School of Hygiene and Tropical Medicine. Claudia’s academic background in Italy covers the range from applied mathematics (MSc 1996), epidemiology and medical statistics (MSc 1998 and PhD-equivalent 2001), to public health and education (PhD 2006). She was elected a Fellow of the UK Higher Education Academy (2012), and an Honorary Member of the UK Faculty of Public Health (2014). She was awarded the Faculty’s inaugural Global Public Health Award in June 2016. She has published over 70 peer-reviewed articles, and co-authored 80 more as a Working Group member. She has written 9 book chapters, manuals and reports. Her research has been cited over 11,000 times (h-index 47, i-10 index 73; Google Scholar). She collaborates with the Organisation for Economic Co-operation and Development (OECD), and with several other international agencies focused on cancer control, including the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC), the American Cancer Society (ACS) and the French National Cancer Institute (INCa), as well as the European Cancer Patient Coalition (ECPC). She has recently contributed to the Digestive Cancers Europe task force to establish a “Roadmap for Colorectal Cancer in Europe”.

Kathy Pritchard-Jones is President of the International Society of Paediatric Oncology (SIOP) and Professor of Paediatric Oncology, University College London Great Ormond Street Institute of Child Health. Kathy’s interests are in improving diagnosis and treatment for children with cancer through international collaboration and research. She leads clinical studies in childhood kidney cancer and uses data to define best practice and compare cancer survival rates. As SIOP President, she is working with the World Health Organisation to support global implementation of their challenge to double childhood cancer survival rates in Low and Middle Income Countries to 60% by 2030.

Dr. Atun is Professor of Global Health Systems at Harvard University and the Faculty Chair of the Harvard Ministerial Leadership Program. In 2008-12 he served as a member of the Executive Management Team of the Global Fund as Director of Strategy, Performance and Evaluation. In 2006-2013 he was a Professor of International Health Management at Imperial College London and led the Centre for Health Management. He is a visiting professor at University of Kyoto, Japan. Professor Atun’s research focuses on health system transformation, and innovation. He has published over 350 papers in leading journals such as NEJM, The Lancet, The Lancet Oncology and the Academy of Management Journal. Prof Atun has advised more than 30 governments on health policy and health system reform, and has worked with the World Bank, WHO and other leading organizations. Professor Atun studied medicine at University of London as a Commonwealth Scholar. He completed postgraduate training in family medicine and public health, and obtained a Masters in Business Administration at University of London and Imperial College London. He is a Fellow of the Royal College of Physicians, the Faculty of Public Health, and the Royal College of General Practitioners.